Neovasc Inc

Neovasc — Investor Presentation (September 2010)

15 slides from Neovasc's investor presentation, September 2010

  1. Slide 1: Neovasc Tissue Products

    Neovasc Tissue Products September 2010

  2. Slide 2: Neovasc Inc.

    Neovasc Inc. Neovasc Inc. is a medical device company focused on products used to treat heart disease and related conditions Founded: 2000 Location: Vancouver, BC, Canada Employees: ~44 full time Facility: 14,000sqft including labs and cleanrooms Core Products: Custom pericardial tissue Peripatch™ i

  3. Slide 3: Tissue Products Overview

    Tissue Products Overview The focus of the Neovasc Tissue Products Division is to provide biological tissue materials and associated development and manufacturing services. • Our customers are typically industry partners who private label or incorporate Neovasc biological tissue materials into their

  4. Slide 4: Tissue Product Technologies

    Neovasc Tissue Product Technologies • Specially treated pericardial tissue suitable for incorporation into a wide range of implantable devices • Proprietary treatment process creates implantable, biocompatible tissue that retains physical characteristics of natural tissue • Initially developed for s

  5. Slide 5: Tissue Sources

    Neovasc Tissue Sources • We supply pericardial tissue products from the following sources: Bovine - sourced from Australia and New Zealand (GBR1) Bovine - sourced from US (GBR3) Equine - sourced from Canada Porcine - sourced from Canada • Our bovine pericardial tissue products are generally approved

  6. Slide 6: Tissue Physical Characteristics

    Neovasc Tissue Physical Characteristics • Typical thickness ranges: Ultrathin Bovine* 0.20 – 0.30 mm (0.008” – 0.012”) Standard Bovine 0.30 – 0.75 mm (0.012” – 0.030”) Equine 0.20 – 0.50 mm (0.008” – 0.020”) Porcine 0.15 – 0.25 mm (0.006” – 0.010”) * Availability limited please call for details • Pr

  7. Slide 7: Tissue – Current Applications

    Neovasc Tissue – Current Applications 1. Minimally invasive aortic heart valve leaflets 2. Minimally invasive mitral heart valve leaflets 3. Specialty heart valve leaflets and components 4. Artificial heart components 5. Covered stent grafts 6. Surgical patches for vascular procedures 7. Surgical pa

  8. Slide 8: Heart Valve Leaflet Applications

    Neovasc Heart Valve Leaflet Applications Neovasc is the world’s leading third party supplier of cross-linked pericardial tissue for use in the development of minimally invasive heart valves. 8

  9. Slide 9: Facility and Services

    Neovasc Facility and Services Neovasc has a state of the art development and production facility. In addition to providing our standard tissue products, we work closely with partners to provide solutions specific to their products. These activities include: • Providing collagen fixed tissue cut or s

  10. Slide 10: Peripatch™ Surgical Patch

    Peripatch™ Surgical Patch Neovasc’s Peripatch has significant advantages over synthetic materials for surgical patching or repair applications: • Handles like natural tissue • Exceptional tensile and suture retention strength • Does not require special sutures • Reduced suture line bleeding / leakag

  11. Slide 11: Production Scalability

    Production Scalability • Neovasc facility includes chemistry lab, certified ISO Class 5, 6 & 7 cleanrooms and manufacturing infrastructure for a wide range of tissue and vascular medical devices • Neovasc maintains excess cleanroom capacity to be able to respond rapidly to the growing needs of our c

  12. Slide 12: Established and Tested Quality System

    Established and Tested Quality System • Neovasc is certified to EN ISO 13485:2003 and is 22442 compliant • Neovasc is regulated by US-FDA, Health Canada and European notified bodies and follows all applicable standards and guidelines • Neovasc’s facility and Quality System are audited annually by ou

  13. Slide 13: Team

    Neovasc Team The Neovasc team includes a range of professionals experienced in the development of implantable pericardial tissue technologies and vascular devices. Key members of our team include: Alexei Marko (CEO) - 16 years experience in the development and commercialization of medical devices, i

  14. Slide 14: Summary

    Summary Neovasc provides an unmatched level of service to our tissue product customers • We are a leading provider of clinically proven implantable pericardial tissue and associated services to the medical device industry • We have a highly experienced team and state-of-the-art facility that support

  15. Slide 15: Contact Information

    Contact Information Neovasc Inc. 13700 Mayfield Place, Suite 2135 Richmond BC V6V 2E4 Canada D: 604.270.4344 F: 604.270.4384 www.neovasc.com Brian McPherson, COO bmcpherson@neovasc.com Alexei Marko, CEO amarko@neovasc.com 15

Neovasc — Investor Presentation (September 2010) on 6ix